These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24791343)

  • 41. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
    Ozden MG; Tekin NS; Ilter N; Ankarali H
    Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
    Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
    J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis.
    Chosidow O; Maurette C; Dupuy P
    Dermatology; 2003; 206(3):233-40. PubMed ID: 12673081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Observational evaluation of sertaconazole nitrate cream 2% in the treatment of pruritus related to tinea pedis.
    Kircik LH
    Cutis; 2009 Nov; 84(5):279-83. PubMed ID: 20099622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind, placebo-controlled pilot study to estimate the efficacy and tolerability of a nonsteroidal cream for the treatment of cradle cap (seborrheic dermatitis).
    David E; Tanuos H; Sullivan T; Yan A; Kircik LH
    J Drugs Dermatol; 2013 Apr; 12(4):448-52. PubMed ID: 23652893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
    Elewski B; Ling MR; Phillips TJ
    J Drugs Dermatol; 2006; 5(7):646-50. PubMed ID: 16865870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Meta-Analysis on the Effectiveness of Sertaconazole 2% Cream Compared with Other Topical Therapies for Seborrheic Dermatitis.
    Georgescu SR; Mitran CI; Mitran MI; Amuzescu A; Matei C; Tampa M
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of sebopsoriasis. A clinical trial--an etiological approach.
    Döring HF
    Dermatologica; 1984; 169 Suppl 1():125-33. PubMed ID: 6241159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seborrheic dermatitis in otherwise healthy patients and in patients with lymphadenopathy syndrome/AIDS-related complex: treatment with 1% bifonazole cream.
    Massone L; Borghi S; Pestarino A; Piccini R; Solari G; Casini Lemmi M; Isola V
    Chemioterapia; 1988 Apr; 7(2):109-12. PubMed ID: 2969303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp.
    Gold MH; Bridges T; Avakian EV; Plaum S; Fleischer AB; Hardas B
    J Drugs Dermatol; 2012 Apr; 11(4):514-8. PubMed ID: 22453590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study of 2% sertaconazole solution and cream formulations in patients with tinea corporis, tinea pedis interdigitalis, or a corresponding candidosis.
    Borelli C; Klövekorn G; Ernst TM; Bödeker RH; Korting HC; Neumeister C
    Am J Clin Dermatol; 2007; 8(6):371-8. PubMed ID: 18039020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and efficacy of sertaconazole nitrate cream 2% in the treatment of tinea pedis interdigitalis: a subgroup analysis.
    Borelli C; Korting HC; Bödeker RH; Neumeister C
    Cutis; 2010 Feb; 85(2):107-11. PubMed ID: 20349685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial.
    Ghodsi SZ; Abbas Z; Abedeni R
    Am J Clin Dermatol; 2015 Oct; 16(5):431-7. PubMed ID: 26016699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sertaconazole in the treatment of mycoses: from dermatology to gynecology.
    Torres J; Márquez M; Camps F
    Int J Gynaecol Obstet; 2000 Dec; 71 Suppl 1():S3-20. PubMed ID: 11118560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.
    Lebwohl M; Plott T
    Int J Dermatol; 2004 Jul; 43 Suppl 1():17-20. PubMed ID: 15271196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study.
    Shin H; Kwon OS; Won CH; Kim BJ; Lee YW; Choe YB; Ahn KJ; Eun HC
    J Dermatol; 2009 Mar; 36(3):131-7. PubMed ID: 19335686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ciclopirox gel for seborrheic dermatitis of the scalp.
    Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Double-blind comparative study of RO-13-8996 with miconazole in relation to its efficiency and local tolerance in patients with dermatomycosis].
    Arreaza de Arreaza F; Díaz de Torres E; Briceño Maaz T
    Med Cutan Ibero Lat Am; 1984; 12(1):57-61. PubMed ID: 6376980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrhoeic dermatitis.
    Zienicke H; Korting HC; Braun-Falco O; Effendy I; Hagedorn M; Küchmeister B; Meisel C
    Mycoses; 1993; 36(9-10):325-31. PubMed ID: 8015566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial.
    Altmeyer P; Hoffmann K;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():9-12. PubMed ID: 15271194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.